Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Antipodean Advisors LLC

Q4 2022 · 13F-HR

Antipodean Advisors LLCholdings as filed

Filed 2023-02-13 · accession 0000919574-23-001146

$29.9M
Reported value
8
Positions
2022-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
81141R100SESEA LTD$18.2M60.8%350,000CommonSOLE
78463V107GLDSPDR GOLD TR$5.9M19.8%35,000CommonSOLE
046513107ATRAGBXATARA BIOTHERAPEUTICS INC$3.3M11.0%1,000,000CommonSOLE
14171W103CAREMAX INC$1.6M5.18%425,000CommonSOLE
14161W105CDLXCARDLYTICS INC$433,5001.45%75,000CommonSOLE
92189F106GDXVANECK ETF TRUST$286,6000.96%10,000CommonSOLE
91680M107UPSTUPSTART HLDGS INC$132,2000.44%10,000CommonSOLE
146869102CVNACARVANA CO$118,5000.40%25,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.